glp 1 inhibitors How GLP-1 Receptor Agonists Evolved from Diabetes to Weight Loss Treatments GLP-1 Receptor Agonists as Treatments

These statements have not been evaluated by the Food and Drug Administration

Medicare has never paid for weight-loss drugs at scale

With drugs like Ozempic and Wegovy growing in popularity among diabetic patients, CRNAs must be aware of all potential GLP-1 and anesthesia conflicts.

Initially developed to improve glycemic control, these agents are now recognized as important components of cardiovascular risk reduction strategies

### Competing Interest Statement ASK, AMM, MCG, JMD, CB, CL, SWB, DJL, PML, DRD, JMC, JPF, YL, ARS, DAT, DWP, SH, RBR, MSL, and DAG are employees and stockholders of Pfizer Inc

This supports that pharmacies are permitted to compound GLP-1 drugs under section 503A of the Act, provided they adhere to specific conditions outlined by the FDA